Med tech incubator Edison Nation Medical gave FierceMedicalDevices details about the medical devices in its pipeline that are in need of a licensing partner. They range from a simple wand for collecting urine specimens to an asthma inhaler that can be conformed to fit in your wallet.
A Sarepta antisense drug that targets a single ebolavirus protein successfully protected 75% of the rhesus monkeys it was given to, offering some solid animal data to back up the biotech's claim that it has an effective antidote to the lethal disease.
Merck and Novo Nordisk are the latest pharma recruits for the GPCR Consortium, a global nonprofit working to shed light on an underexplored corner of biology and share its discoveries with the public.
The U.S. Defense Advanced Research Projects Agency (DARPA) has made the creation of upper-limb prosthesis, artificial arms and hands that allow for sensory feedback a top priority--it's backing 8 research organizations to do so.
SINGAPORE-- Several Japan drugmakers are making strides toward being major pioneers in the new pharmaceuticals field of nucleic acid-based treartments. A few already have clinical trials in the works for such things as Duchenne muscular dystrophy.
Alkermes' multiple sclerosis prodrug looks good in Phase I, has Biogen Idec's Tecfidera in its sights
Alkermes said the safety profile of its clinical-stage multiple sclerosis drug compares favorably to that of Biogen Idec's Tecfidera, citing the candidate's Phase I trial results on 104 patients.
Researchers at the University of Cambridge say a robot named Eve has discovered that an anticancer compound is a good candidate to combat malaria.
The head of the U.K.'s Trade & Investment Ministry has begun a three-day visit to India to focus on biotech and health issues, beginning with the Bangalore India Bio, the nation's major biotech conference.
As GlaxoSmithKline prepares to fold in the bulk of Novartis' vaccines unit--headed its way after their April 2014 multibillion-dollar asset swap--it's changing things up a little. And that includes closing the R&D branch of its vaccines lab in Hamilton, MT, this year.
Researchers at the The Feinstein Institute for Medical Research have shaped living cells into a cartilage implant for tracheal repair or replacement using a modified MakerBot 3-D printer.